Delivery Order SPE2DB24D2205-SPE2DB24FDSJW
- Not listed
- This is a federal contract award from the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $2,442.25, is for the delivery of Trintellix 10 mg tablets. It is a firm fixed-price delivery order contract with an ultimate completion date of April 28, 2025. The contract is not set aside and is open to full and open competition. AmerisourceBergen Drug Corp holds a significant Indefinite...
- This is a delivery order awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, with a ceiling value of $1,807.82. The order is for the supply of Trintellix 20mg tablets for the DLA. The contract has a firm fixed price pricing type and an ultimate completion date of April 16, 2024. This award is part of a larger Indefinite Delivery Contract (IDC) valued up to $999,999,999.00 that Amerisourcebergen holds with the DLA Troop Support...
- This is a firm fixed-price delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor. The contract, valued at $1,072.80, is for the supply of 4,568,147,296 units of the medication Trintellix 5 mg tablet. The contract has an ultimate completion date of May 6, 2025. AmerisourceBergen Drug Corp is the prime contractor, and there is no set-aside designation for this award. The contract is part of a larger Indefinite Delivery...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on July 15, 2025, for the supply of Trintellix 10 mg tablets in a 30-count package, with a ceiling value of $1,538.48. This firm fixed-price delivery order represents a non-set-aside competitive award and is scheduled for completion by July 16, 2025. The contract will be fulfilled from the vendor's location in Conshohocken, Pennsylvania, where AmerisourceBergen maintains its corporate headquarters. This delivery...
- This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corporation's Corporate Office Division. The Delivery Order, valued at $1,933.17, is for the supply of Trintellix 10 mg tablets. This contract is part of Amerisourcebergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, valued up to $999,999,999.00 through December 2025. Under this IDC, Amerisourcebergen provides a range of pharmaceutical products and medical...
- This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor. The contract is for the supply of Trintellix 5 mg tablets, a neurological medication. The contract has a ceiling value of $5,833.39 and a period of performance through April 23, 2025. It is a firm-fixed-price contract, without any set-aside designation, indicating open competition. AmerisourceBergen Drug Corp holds a larger Indefinite Delivery...
- The Defense Logistics Agency (DLA) awarded a delivery order to AmerisourceBergen Drug Corp for the supply of Trintellix 10 mg tablets (30-count packaging) under a firm fixed-price contract with a ceiling value of $1,309.08. The award, issued on August 1, 2025, with an ultimate completion date of August 4, 2025, represents a non-set-aside competitive award to the prime contractor. AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, will...
- The Defense Logistics Agency (DLA) awarded Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, a firm fixed price delivery order (SPE2DB22D1202|SPE2DB24FUWV1) worth $1,510.80 for the supply of TRINTELLIX 10 MG TABLETs. This delivery order is part of a larger indefinite delivery contract (IDC) awarded solely to Amerisourcebergen Drug Corp, with a potential value of $999,999,999.00 through December 31, 2025. The IDC serves as the primary vehicle for Amerisourcebergen to...
- This federal contract award was made by the Defense Logistics Agency (DLA), a defense agency, to Amerisourcebergen Drug Corp, a major pharmaceutical distribution company. The contract, valued at up to $1,216.24, is a delivery order for the supply of Trintellix 5 mg tablets. The contract is part of a larger Indefinite Delivery Contract (IDC) that Amerisourcebergen holds with the DLA Troop Support Medical, valued at up to $999,999,999.00 through December 31, 2025. Under this single-award IDC,...
- This is a firm fixed-price delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $1,575.48, is for the supply of Trintellix 5 mg tablets and does not have a set-aside designation. AmerisourceBergen holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at $999,999,999 and running through November 2026, which serves as a...
- SPE2DB24D2205Indefinite Delivery Contract
- SPE2DB24D2205-SPE2DB24FDSJWDelivery Order
The U.S. Defense Logistics Agency (DLA) awarded a firm fixed price delivery order contract to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, to provide the pharmaceutical product Trintellix 10 mg tablet 30s. The contract has a ceiling value of $1,014.58 and a period of performance through April 10, 2024. This award is a task order under an indefinite delivery contract (IDC) held by Amerisourcebergen Drug Corp with DLA, which has a potential value of up to $999,999,999.00 and runs through December 31, 2025. The IDC serves as Amerisourcebergen's primary contract vehicle for delivering pharmaceuticals and medical supplies to DLA Troop Support Medical facilities supporting the Department of Defense. No set-aside designation was used for this specific award.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $1.0k | 4/9/24 |